Immunology for Engineers Advances in Protein Chemistry and Structural Biology Series

Immunology for Engineers, Volume 140 consists of chapters from stalwarts of the field, covering topics such as antibody engineering, adjuvant requirement and its methodology for assessment, and the need to develop immunotherapy, etc. Chapters covered in this volume discuss Current Status and Future Prospective of Breast Cancer Immunotherapy, Engineering high affinity antigen binders- beyond antibodies, Platelets and Inter-Cellular Communication in Immune Responses: Dialogue with both Professional and Non-Professional Immune Cells, Chimeric Antigen Receptor (CAR) T cell-based cancer immunotherapy: A boon for cancer-free life, and Molecular insights and promise of Oncolytic Virus based Immunotherapy.

1. Preface
Vijay Kumar Prapajati
2. Current Status and Future Prospective of Breast Cancer Immunotherapy
Anurag S. Rathore
3. Engineering high affinity antigen binders- beyond antibodies
Rajeev Kumar Pandey
4. Platelets and Inter-Cellular Communication in Immune Responses: Dialogue with both Professional and Non-Professional Immune Cells
Sunil Kumar SINGH
5. Chimeric Antigen Receptor (CAR) T cell-based cancer immunotherapy: A boon for cancer-free life
Bajarang Vasant Kumbhar
6. Molecular insights and promise of Oncolytic Virus based Immunotherapy
Balachandar Vellingiri

Dr. Vijay Kumar Prajapati is working as Associate Professor at Department of Biochemistry, University of Delhi South Campus, New Delhi, India. He has extensive experience on drug discovery and vaccine development for infectious diseases. He has published approx. 100 research articles in the international journal with >10 book chapters with reputed publishers. He is a recipient of prestigious INSA Medal for Young Scientist from Indian National Science Academy (INSA) and Associate from Indian Academy of Sciences, Benguluru. He has published research work in the prestigious journal such as Journal of Infectious Diseases, Clinical Infectious Diseases, Scientific Reports, Medicinal Research Review, Journal of Cellular Physiology etc. His current h-index is 38 with 4373 citations. .